Novavax reported $4.08B in Market Capitalization this May of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
AstraZeneca AZN:LN 134.46B 4.31B
Genocea Biosciences GNCA:US $ 0.07B 0.01B
Geron GERN:US $ 0.44B 0.05B
Minerva Neurosciences NERV:US $ 0.04B 0B
Pain Therapeutics PTIE:US $ 1.49B 0.26B
Peregrine Pharmaceuticals PPHM:US $ 1.32B 0.24B
Sanofi SAN:FP 111.92B 6.96B
Tg Therapeutics TGTX:US $ 2.72B 2.04B